These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24421317)

  • 21. Three-dimensional structure of the FK506 binding protein/ascomycin complex in solution by heteronuclear three- and four-dimensional NMR.
    Meadows RP; Nettesheim DG; Xu RX; Olejniczak ET; Petros AM; Holzman TF; Severin J; Gubbins E; Smith H; Fesik SW
    Biochemistry; 1993 Jan; 32(3):754-65. PubMed ID: 7678499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A photocleavable rapamycin conjugate for spatiotemporal control of small GTPase activity.
    Umeda N; Ueno T; Pohlmeyer C; Nagano T; Inoue T
    J Am Chem Soc; 2011 Jan; 133(1):12-4. PubMed ID: 21142151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of solvent-exposed regions of an FK-506 analog, ascomycin, bound to FKBP using a paramagnetic probe.
    Petros AM; Neri P; Fesik SW
    J Biomol NMR; 1992 Jan; 2(1):11-8. PubMed ID: 1384850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dimer formation of receptor activator of nuclear factor kappaB induces incomplete osteoclast formation.
    Iwamoto K; Miyamoto T; Sawatani Y; Hosogane N; Hamaguchi I; Takami M; Nomiyama K; Takagi K; Suda T
    Biochem Biophys Res Commun; 2004 Dec; 325(1):229-34. PubMed ID: 15522223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel inducible tyrosine kinase receptor to regulate signal transduction and neurite outgrowth.
    Alfa RW; Tuszynski MH; Blesch A
    J Neurosci Res; 2009 Sep; 87(12):2624-31. PubMed ID: 19405107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A synthetic library of cell-permeable molecules.
    Koide K; Finkelstein JM; Ball Z; Verdine GL
    J Am Chem Soc; 2001 Jan; 123(3):398-408. PubMed ID: 11456541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanistic studies of a signaling pathway activated by the organic dimerizer FK1012.
    Pruschy MN; Spencer DM; Kapoor TM; Miyake H; Crabtree GR; Schreiber SL
    Chem Biol; 1994 Nov; 1(3):163-72. PubMed ID: 9383386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FKBP family proteins: immunophilins with versatile biological functions.
    Kang CB; Hong Y; Dhe-Paganon S; Yoon HS
    Neurosignals; 2008; 16(4):318-25. PubMed ID: 18635947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Making molecular matches in the cell.
    Travis J
    Science; 1993 Nov; 262(5136):989. PubMed ID: 7694368
    [No Abstract]   [Full Text] [Related]  

  • 30. Solution structure of FK506 bound to FKBP-12.
    Lepre CA; Thomson JA; Moore JM
    FEBS Lett; 1992 May; 302(1):89-96. PubMed ID: 1375171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid protein-ligand docking using soft modes from molecular dynamics simulations to account for protein deformability: binding of FK506 to FKBP.
    Zacharias M
    Proteins; 2004 Mar; 54(4):759-67. PubMed ID: 14997571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Plasmodium falciparum FK506-binding protein (FKBP) with peptidyl-prolyl cis-trans isomerase and chaperone activities.
    Monaghan P; Bell A
    Mol Biochem Parasitol; 2005 Feb; 139(2):185-95. PubMed ID: 15664653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1H, 13C, and 15N assignments and secondary structure of the FK506 binding protein when bound to ascomycin.
    Xu RX; Nettesheim D; Olejniczak ET; Meadows R; Gemmecker G; Fesik SW
    Biopolymers; 1993 Apr; 33(4):535-50. PubMed ID: 7682113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Competitive and slow-binding inhibition of calcineurin by drug x immunophilin complexes.
    Salowe SP; Hermes JD
    Arch Biochem Biophys; 1998 Jul; 355(2):165-74. PubMed ID: 9675023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Hsp56 component of steroid receptor complexes binds to immobilized FK506 and shows homology to FKBP-12 and FKBP-13.
    Yem AW; Tomasselli AG; Heinrikson RL; Zurcher-Neely H; Ruff VA; Johnson RA; Deibel MR
    J Biol Chem; 1992 Feb; 267(5):2868-71. PubMed ID: 1371107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retention of immunosuppressant activity in an ascomycin analogue lacking a hydrogen-bonding interaction with FKBP12.
    Wiedeman PE; Fesik SW; Petros AM; Nettesheim DG; Mollison KW; Lane BC; Or YS; Luly JR
    J Med Chem; 1999 Oct; 42(21):4456-61. PubMed ID: 10543889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NMR and crystallographic structures of the FK506 binding domain of human malarial parasite Plasmodium vivax FKBP35.
    Alag R; Qureshi IA; Bharatham N; Shin J; Lescar J; Yoon HS
    Protein Sci; 2010 Aug; 19(8):1577-86. PubMed ID: 20572013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific interaction of type I receptors of the TGF-beta family with the immunophilin FKBP-12.
    Wang T; Donahoe PK; Zervos AS
    Science; 1994 Jul; 265(5172):674-6. PubMed ID: 7518616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conformation of two non-immunosuppressive FK506 analogs when bound to FKBP by isotope-filtered NMR.
    Petros AM; Kawai M; Luly JR; Fesik SW
    FEBS Lett; 1992 Aug; 308(3):309-14. PubMed ID: 1380470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heteronuclear 3D NMR studies of water bound to an FK506 binding protein/immunosuppressant complex.
    Xu RX; Meadows RP; Fesik SW
    Biochemistry; 1993 Mar; 32(10):2473-80. PubMed ID: 7680570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.